Evonik and Mobile: Our Success Story From humble beginnings in the 1970’s, Evonik’s Mobile, Alabama chemical production site has grown into the company’s largest chemical manufacturing plant in North America ... MORE
4,500,000 Hours Without an Accident In 2018, the Mobile chemical site surpassed 4,500,000 hours worked without a Lost Time Accident, an exemplary achievement for the industry. Evonik has continuously invested in infrastructure and personnel training to make sure our teams stay safe ... MORE
A Leading Employer in the Region With about 1,100 full time and contractor positions, Evonik is proud to be one of the largest employers in the Mobile area. Our outstanding reputation in the community allows us to selectively hire from top talent pools and operate a top-tier production facility. ... MORE
What Do We Do? Even if you don't recognize us by name, you will recognize Evonik by the products we make in the Mobile community. You use Evonik chemistry every day in many different ways ... MORE
North America Jun 06, 2023 Evonik Receives American Chemistry Council’s Sustainability Leadership Award Award for Product Safety, Innovation & Transparency goes to biosurfactant RHEANCE® One. ... MORE
Company May 09, 2023 Weak economy characterizes difficult first quarter Despite a difficult first quarter, Evonik confirms its earnings forecast for 2023. ... MORE
North America Apr 24, 2023 Evonik reaches settlement with EPA Company agrees to $75,000 civil penalty for violating permitted emission limits for hazardous air pollutants in Reserve, La. New control technologies and a supplemental environmental program will reduce emissions. ... MORE
VESTAKEEP for Implants Apr 21, 2023 Evonik’s VESTAKEEP® i4 3DF PEEK filament biomaterial was used in the first US surgeries for 3D printed spinal implants Curiteva’s world’s first 3D printed spinal implants for commercial use are based on Evonik’s VESTAKEEP® i4 3DF biomaterial filament. ... MORE
Health Care Mar 29, 2023 Evonik breaks ground on $220 million Lipid Innovation Center in Lafayette, Indiana Evonik’s Lipid Innovation Center is being built on the grounds of the company’s site in Tippecanoe and will position Evonik for future growth in novel mRNA-based therapies beyond COVID-19 vaccines. ... MORE
Company Mar 02, 2023 Evonik delivers: Robust earnings in difficult environment After a challenging year 2022, Evonik is cautiously optimistic for 2023. ... MORE